Martin Spiegel

Dr. Martin Spiegel

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 July 2016 in Viruses
Verified
Journal Article
Open access
PDF file
MSMartin Spiegel
Martin Spiegel
TPTeresa Plegge
Teresa Plegge
Stefan PöhlmannStefan Pöhlmann
Stefan Pöhlmann
Bunyaviruses are enveloped viruses with a tripartite RNA genome that can pose a serious threat to animal and human health. Members of the Phlebovirus genus of the family Bunyaviridae are transmitted by mosquitos and ticks to humans and include highly pathogenic agents like Rift Valley fever virus (RVFV) and severe fever with thrombocytopenia syndrome virus (SFTSV) as well as viruses that do not cause disease in humans, like Uukuniemi virus (UUKV). Phleboviruses and other bunyaviruses use their envelope proteins, Gn and Gc, for entry into target cells and for assembly of progeny particles in infected cells. Thus, binding of Gn and Gc to cell surface factors promotes viral attachment and uptake into cells and exposure to endosomal low pH induces Gc-driven fusion of the viral and the vesicle membranes. Moreover, Gn and Gc facilitate virion incorporation of the viral genome via their intracellular domains and Gn and Gc interactions allow the formation of a highly ordered glycoprotein lattice on the virion surface. Studies conducted in the last decade provided important insights into the configuration of phlebovirus Gn and Gc proteins in the viral membrane, the cellular factors used by phleboviruses for entry and the mechanisms employed by phlebovirus Gc proteins for membrane fusion. Here, we will review our knowledge on the glycoprotein biogenesis and the role of Gn and Gc proteins in the phlebovirus replication cycle.

23 February 2011 in Physics in Medicine & Biology
Verified
Journal Article
Closed access
DSD Schuldhaus
D Schuldhaus
MSMartin Spiegel
Martin Spiegel
TRT Redel
T Redel
MPM Polyanskaya
M Polyanskaya
TST Struffert
T Struffert
ADA Doerfler
A Doerfler
X-ray-based 2D digital subtraction angiography (DSA) plays a major role in the diagnosis, treatment planning and assessment of cerebrovascular disease, i.e. aneurysms, arteriovenous malformations and intracranial stenosis. DSA information is increasingly used for secondary image post-processing such as vessel segmentation, registration and comparison to hemodynamic calculation using computational fluid dynamics. Depending on the amount of injected contrast agent and the duration of injection, these DSA series may not exhibit one single DSA image showing the entire vessel tree. The interesting information for these algorithms, however, is usually depicted within a few images. If these images would be combined into one image the complexity of segmentation or registration methods using DSA series would drastically decrease. In this paper, we propose a novel method automatically splitting a DSA series into three parts, i.e. mask, arterial and parenchymal phase, to provide one final image showing all important vessels with less noise and moving artifacts. This final image covers all arterial phase images, either by image summation or by taking the minimum intensities. The phase classification is done by a two-step approach. The mask/arterial phase border is determined by a Perceptron-based method trained from a set of DSA series. The arterial/parenchymal phase border is specified by a threshold-based method. The evaluation of the proposed method is two-sided: (1) comparison between automatic and medical expert-based phase selection and (2) the quality of the final image is measured by gradient magnitudes inside the vessels and signal-to-noise (SNR) outside. Experimental results show a match between expert and automatic phase separation of 93%/50% and an average SNR increase of up to 182% compared to summing up the entire series.

1 February 2003 in Molecular Therapy
Verified
Journal Article
Open access
MBMichael Bitzer
Michael Bitzer
GUGuy Ungerechts
Guy Ungerechts
SBSascha Bossow
Sascha Bossow
FGFlorian Graepler
Florian Graepler
RSReinhard Sedlmeier
Reinhard Sedlmeier
ULUlrich Lauer
Ulrich Lauer
Treatment by gene replacement is critical in the field of gene therapy. Suitable vectors for the delivery of therapeutic genes have to be generated and tested in preclinical settings. Recently, extraordinary features for a local gene delivery by Sendai virus vectors (SeVV) have been reported for different tissues. Here we show that direct intravenous application of SeVV in mice is not only feasible and safe, but it results in the secretion of therapeutic proteins to the circulation, for example, human clotting Factor IX (hFIX). In vitro characterization of first-generation SeVV demonstrated that secreted amounts of hFIX were at least comparable to published results for retroviral or adeno-associated viral vectors. Furthermore, as a consideration for application in humans, SeVV transduction led to efficient hFIX synthesis in primary human hepatocytes, and SeVV-encoded hFIX proteins could be shown to be functionally active in the human clotting cascade. In conclusion, our investigations demonstrate for the first time that intravenous administration of negative-strand RNA viral vectors may become a useful tool for the wide area of gene replacement requirements.

25 June 2024 in Microorganisms
Verified
Journal Article
Open access
PDF file
CHCecilia Heller
Cecilia Heller
IBIris Bachmann
Iris Bachmann
MSMartin Spiegel
Martin Spiegel
FHFrank Torsten Hufert
Frank Torsten Hufert
GDGregory Dame
Gregory Dame
Rapid and accurate detection of Klebsiella pneumoniae carbapenem resistance is important for infection control and targeted antibiotic therapy. PCR-based assay performance heavily depends on the quality and quantity of template DNA. Challenges arise from the necessity to isolate chromosomal and large plasmid-encoded resistance genes simultaneously from a limited number of target cells and to remove PCR inhibitors. qPCRs for the detection of K. pneumoniae strains carrying blaOXA-48, blaNDM-1, blaKPC-2, and blaVIM-1 carbapenemase genes were developed. We compared the performance of template DNA extracted with silica column-based methods, reversed elution systems, and lysis-only methods either from diluted culture fluid or from a synthetic stool matrix which contained PCR inhibitors typically present in stool. The synthetic stool matrix was chosen to mimic K. pneumoniae containing rectal swabs or stool samples in a reproducible manner. For total DNA isolated from culture fluid, resistance gene detection by qPCR was always possible, independent of the extraction method. However, when total DNA was isolated from synthetic stool matrix spiked with K. pneumoniae, most methods were insufficient. The best performance of template DNA was obtained with reversed elution. This highlights the importance of choosing the right DNA extraction method for consistent carbapenem resistance detection by PCR.

1 April 2020 in Monatsschrift Kinderheilkunde
Verified
Journal Article
Closed access
PDF file
FHFrank Torsten Hufert
Frank Torsten Hufert
MSMartin Spiegel
Martin Spiegel

2 August 2025 in Influenza and Other Respiratory Viruses
Verified
Journal Article
Open access
BBBenedikt Beilstein
Benedikt Beilstein
IBIris Bachmann
Iris Bachmann
MSMartin Spiegel
Martin Spiegel
FHFrank T. Hufert
Frank T. Hufert
GDGregory Dame
Gregory Dame
Background: Nucleic acid amplification tests (NAATs) for human adenoviruses (HAdVs) causing respiratory infections usually target the hexon gene. However, new HAdV types with substantial variations in the hexon gene may not be detected. Thus, we focus on NAATs based on a conserved region in the penton gene to detect all HAdV types causing respiratory infections.Methods: A highly conserved region at the 3′ end of the penton gene was chosen as a target for NAAT. Primers and probes for quantitative polymerase chain reaction (qPCR) and isothermal recombinase polymerase amplification (RPA) were designed for the detection of all HAdV types causing respiratory infections.Results: Two highly sensitive qPCR assays were established, one for the detection of HAdV‐E4 and HAdV‐B types and another for the detection of HAdV‐C types (LOD < 10 standard DNA copies for both assays). Furthermore, a one‐tube RPA with a universal RPA probe was developed for rapid detection of all HAdV types causing respiratory infections (LOD ≤ 244 standard DNA copies). All three assays were used for testing clinical nasopharyngeal swabs obtained from SARS‐CoV‐2‐negative children with respiratory disease symptoms. Eight out of 243 samples tested were found to be HAdV positive by qPCR and by one‐tube RPA, except for one sample with a very low viral load of 30 genome equivalents.Conclusions: Penton gene‐based NAAT systems were developed and successfully used for the detection of HAdV in clinical samples. The newly developed one‐tube RPA assay offers the possibility for rapid and simple detection of respiratory HAdV infections at the point of need.